CVE-2025-62552
Microsoft Access Remote Code Execution Vulnerability
Relative path traversal in Microsoft Office Access allows an unauthorized attacker to execute code locally.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Required
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
CVE List Score used
Microsoft Access Remote Code Execution Vulnerability
Relative path traversal in Microsoft Office Access allows an unauthorized attacker to execute code locally.
- Record
CVE-2025-62552- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H/E:U/RL:O/RC:C - Weakness
- CWE-23
- Updated
- 2026-11-02
EUVDEUVD-2025-202220
Relative path traversal in Microsoft Office Access allows an unauthorized attacker to execute code locally.
- Record
EUVD-2025-202220- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H/E:U/RL:O/RC:C - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-gg49-cx5h-392x
Relative path traversal in Microsoft Office Access allows an unauthorized attacker to execute...
Relative path traversal in Microsoft Office Access allows an unauthorized attacker to execute code locally.
- Record
GHSA-gg49-cx5h-392x- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H - Weakness
- CWE-23
- Updated
- 2026-11-02
NVD
Relative path traversal in Microsoft Office Access allows an unauthorized attacker to execute code locally.
- Record
CVE-2025-62552- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H - Weakness
- CWE-23
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2025-62552 is a high vulnerability (CVSS 7.8) in Microsoft Access, published December 9, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.60%, the 48th percentile. No source names a fixed version.